Investor mix
6 investors on record; lead investors include Syngenta Group Ventures, Auriga Partners, ProVen VCT, Noble Fund Managers; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Other / undisclosed | 3 | 50% |
Developing and out-licensing biochemical tools and approaches for NGS applications
6 investors on record; lead investors include Syngenta Group Ventures, Auriga Partners, ProVen VCT, Noble Fund Managers; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 50% |
| Other / undisclosed | 3 | 50% |